Send feedback

BTD p.Arg128Cys

c.382C>T · rs137877018 · VCV373539

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.1757 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0107%, afr)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
biotinidase deficiency

Computational evidence

Protein change
AlphaMissense0.1757likely benign
REVEL0.49indeterminate
SaProtLLR -10.72damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.1GERP 0.36, phastCons 0.39
Regional constrainto/e 1.04unconstrained · MANE · 10 kb · p 0.35 · regional, not allelic
Overall
CADD25.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R148C vs ClinVar R128C) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0107% African / African-American · 8/74,924 alleles
Filtering AF 0.00596% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00549%
Overall 0.00756% 122/1,614,008 alleles · ultra-rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0352% 2,840
African / African-Americangrpmax 0.0107% 9,365
Finnishnot grpmax-eligible 0.00937% 10,671
European (non-Finnish) 0.0072% 13,883
East Asian 0.00223% 44,880

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BTD
Protein
p.Arg128Cys
Coding
c.382C>T
MANE Select
NM_001370658
dbSNP
rs137877018
Type
single nucleotide variant
Location
chr3:15642040 (GRCh38)
Gene constraint
LOEUF 1.22 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 86.77
Residue 128
the cn hydrolase domain
Full BTD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

biotinidase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Biotinidase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Childhood, Infancy, Neonatal
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/btd-p-arg128cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown